The dose-dependent nature of HSPA1A/B levels in response to radiation directly results in maximum release of HSPA1A/B into the serum by 24 hours post-exposure and returned to baseline values by 96 hours in both human xenografts and syngeneic tumor-bearing mice. Here, HSPA1A is linked to neoplasm.